Author

Mary A. Kelley

Observed name: Mary Kelley

Institution: Tonix Pharmaceuticals (United States)

Observed institutions: Harvard University, Massachusetts General Hospital, Tonix Pharmaceuticals (United States), The University of Texas at Austin

ORCID: 0009-0007-1309-1780

Observed ORCID: 0009-0007-1309-1780

OpenAlex ID: A5045979626

Clinical characteristics of Long COVID patients presenting to a dedicated academic post-COVID-19 clinic in Central Texas

2023 · Rija Aziz, Nadia Siles, et al. · Scientific Reports · 39

Intraepidermal Nerve Fiber Density as Measured by Skin Punch Biopsy as a Marker for Small Fiber Neuropathy: Application in Patients with Fibromyalgia

2021 · Mary A. Kelley, Kevin V. Hackshaw · Diagnostics · 25

Pain relief by targeting nonrestorative sleep in fibromyalgia: a phase 3 randomized trial of bedtime sublingual cyclobenzaprine

2025 · Seth Lederman, Lesley M Arnold, et al. · Pain Medicine · 23

Association of small-fiber polyneuropathy with three previously unassociated rare missense SCN9A variants

2020 · Mary A. Kelley, Anne Louise Oaklander · Canadian Journal of Pain · 13

2024 · Mary A. Kelley, John A. Bertelson · Oxford University Press eBooks

Works count: 5

Citation count: 100

H-index: 4

I10-index: 4